Treatment of Vulvovaginal Candidiasis (VVC)

Classification First

Type	Definition
Uncomplicated	Mild-moderate, infrequent episodes, likely C. albicans, immunocompetent host
Complicated	Severe/recurrent (≥4/year), non-albicans species, pregnancy, uncontrolled diabetes, immunosuppression

1. Uncomplicated VVC

Oral (preferred by most patients)

Fluconazole 150 mg PO - single dose
- FDA-approved, ~80-90% cure rate
- Contraindicated in pregnancy

Topical Azoles (intravaginal)

These are equally effective; several are OTC:

Agent	Regimen
Clotrimazole	100 mg tablet x 7 days, OR 2 x 100 mg tablets x 3 days
Miconazole	1200 mg vaginal suppository - single dose, OR 200 mg x 3 days, OR 100 mg x 7 days
Butoconazole	2% cream, single dose
Terconazole	80 mg suppository x 3 days, or 0.4% cream x 7 days
Tioconazole	6.5% ointment - single dose
Nystatin	100,000 unit vaginal tablet x 14 days (less effective than azoles)

Topical azoles are more effective than nystatin. Short-course (1-3 day) and 7-day regimens are both acceptable for uncomplicated VVC.

2. Complicated VVC (Severe or Recurrent)

Severe VVC

Fluconazole 150 mg PO x 2 doses, 72 hours apart, OR
Topical azole for 7-14 days

Recurrent VVC (RVVC - ≥4 episodes/year)

Induction: Fluconazole 150 mg every 72 hours x 3 doses
Maintenance (suppressive) therapy:
- Fluconazole 150 mg PO weekly x 6 months, OR
- Topical clotrimazole 200 mg twice weekly x 6 months

3. Special Populations

Pregnancy

Oral fluconazole is contraindicated (linked to miscarriage and stillbirth, even at low doses - Harrison's 22E)
Use topical azoles only for 7 days
Clotrimazole or miconazole are preferred

Non-albicans VVC (e.g., C. glabrata, C. krusei)

Topical or oral non-fluconazole azole agent (e.g., terconazole, itraconazole)
For recurrence: Boric acid 600 mg vaginal suppository twice daily x 14 days
Note: C. glabrata and C. krusei are intrinsically less susceptible to fluconazole

Immunocompromised / HIV

Oral fluconazole 100-200 mg daily x 7-14 days
Higher doses and longer courses often needed

4. Partner Treatment

Treatment of asymptomatic male partners is not routinely indicated and of no proven benefit
Male partners who develop symptomatic Candida balanitis can use topical antifungal cream

5. Self-Treatment Caution

Women should only self-treat if they have classic symptoms + a prior documented episode confirmed by a clinician. Most women who self-purchase OTC antifungals do not actually have VVC; other vaginal infections (BV, trichomoniasis) require different treatment. - Harrison's 22E

Recent Evidence Note

A 2025 global guideline (Lancet Infect Dis, PMID 39956121) from ECMM/ISHAM/ASM addresses candidiasis management. A 2024 review (PMID 39771534) specifically covers fluconazole-resistant VVC - an emerging concern where ibrexafungerp (a novel triterpenoid oral antifungal) is an emerging option for fluconazole-resistant cases (Phase III RCT, PMID 38568411).

Sources: Rosen's Emergency Medicine; Swanson's Family Medicine; Harrison's Principles of Internal Medicine 22E; Red Book 2021 (AAP)

This is a shared conversation. Sign in to Orris to start your own chat.